We therefore quantified mRNA levels for HMGCR and SQLE in an ERα breast cancer patient treated with AI for whom we had longitudinal data (RNA obtained at diagnosis, first relapse and in circulating metastatic cells from pleural effusion). This evidence concerns the gene HMGCR and breast carcinoma.